Shuhui Chen

Title: Shuhui Chen: Innovator in Ophthalmic Biotechnology

Introduction

Shuhui Chen is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of ophthalmic biotechnology, particularly in the development of novel therapeutic agents for eye diseases. His work focuses on innovative solutions to combat glaucoma and ocular hypertension.

Latest Patents

Shuhui Chen holds a patent for "Isoquinolinone derivatives serving as ROCK protein kinase inhibitors and use thereof." This patent discloses a series of isoquinolone derivatives that act as ROCK protein kinase inhibitors. These compounds are particularly useful in preparing medicaments for conditions related to ROCK protein kinase inhibitors, such as glaucoma or ocular hypertension. The patent specifically highlights a compound of formula (I), its isomers, and pharmaceutically acceptable salts.

Career Highlights

Shuhui Chen is currently employed at Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. His role at the company allows him to apply his expertise in developing innovative treatments for eye-related conditions. His dedication to research and development has positioned him as a key figure in the field.

Collaborations

Shuhui Chen collaborates with Yizhi Liu, a talented woman in the field. Together, they work on advancing the understanding and treatment of ocular diseases through innovative research.

Conclusion

Shuhui Chen's contributions to ophthalmic biotechnology and his innovative patent work demonstrate his commitment to improving eye health. His ongoing research and collaborations continue to pave the way for new therapeutic options in the treatment of glaucoma and ocular hypertension.